Genes, Disease and Therapy Program, IDIBELL
Programa de Gens, Malaltia i Teràpia, IDIBELL

Spain

1 December 2019 - 30 November 2020

No articles found. Genes, Disease and Therapy Program, IDIBELL did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

Bellvitge Biomedical Research Institute (IDIBELL)

↳ Genes, Disease and Therapy Program, IDIBELL

Modeling Human Disease in C. elegans Group, IDIBELL

Cancer Epigenetics and Biology Program (PEBC), IDIBELL

Cancer and Human Molecular Genetics, IDIBELL

Cognition and Brain Plasticity Unit, IDIBELL

Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL

Cancer Prevention and Control Group, IDIBELL

Molecular Mechanisms and Experimental Therapy in Oncology Program, IDIBELL

Colorectal Cancer Research Group (CRC), IDIBELL

Oncobell Program, IDIBELL

Program Against Cancer Therapeutic Resistance (ProCure), IDIBELL

Translational Research Laboratory, IDIBELL

Return to institution outputs

Latest supplement

Nature Index 2020 Artificial Intelligence

Artificial intelligence is one of the most rapidly advancing and controversial topics in scientific research. As investments and revenues soar year-on-year and nations vie for leadership in the field, AI research output continues its steep, upward trajectory. But there are significant ethical and technical challenges to overcome.

Access free